Psoriasis im JDDG
89 Artikel in dieser Kategorie
-
No abstract supplied.Weiterlesen
- 255 Aufrufe
-
No abstract supplied.Weiterlesen
- 277 Aufrufe
-
Background and objectives Up to 30% of psoriasis (PsO) is clinically associated with psoriatic arthritis (PsA). A large proportion of new onset of PsA is diagnosed at a later stage, despite the necessity of early effective treatment to prevent structural damage. This study aimed to identify the routine screening practices used for PsA in patients with PsO.Patients and methods This non-interventional, prospective, epidemiological, cross-sectional study conducted in Germany focuses on screening ac
- 297 Aufrufe
-
No abstract supplied.Weiterlesen
- 274 Aufrufe
-
No abstract supplied.Weiterlesen
- 349 Aufrufe
-
Background and objectives De-escalation strategies of biologics in psoriasis treatment are widespread in clinical practice. Dose spacing consists of de-escalating the time range between biological drug injections.Patients and methods Major objectives were: to describe trends in mean PASI, PASI 100, 90, and ≤ 1 from baseline to 12 months after dose spacing, provide drug survival analysis of dose-spaced regimens, and concurrently describe phenotypic characteristics related to the selection of pati
- 470 Aufrufe
-
No abstract supplied.Weiterlesen
- 483 Aufrufe
-
Background and objectives Generalized pustular psoriasis (GPP) is a rare, chronic, potentially life-threatening skin disease. We aimed to establish criteria to accurately approximate GPP prevalence in Germany.Methods A retrospective analysis of the WIG2 health claims database (1/1/2016-31/12/2020) was conducted. Patients aged ≥ 12 years continuously enrolled in their statutory health insurance with one inpatient or confirmed outpatient diagnosis code for GPP (International Classification of Dise
- 411 Aufrufe
-
No abstract supplied.Weiterlesen
- 321 Aufrufe
-
No abstract supplied.Weiterlesen
- 353 Aufrufe
-
No abstract supplied.Weiterlesen
- 335 Aufrufe
-
No abstract supplied.Weiterlesen
- 343 Aufrufe
-
Vaccination is a fundamental principle of preventive health care. Administration of the vaccine, which contains the antigen(s) of a pathogen, activates the immune system and provides protection against infection. The immunogenicity and allergenicity of a vaccine may lead to various adverse reactions, depending on the responsiveness and susceptibility of the vaccinated individual. Cutaneous adverse events are among the most common and can manifest as various local or generalized vaccination react
- 329 Aufrufe
-
No abstract supplied.Weiterlesen
- 428 Aufrufe
